Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00780026 · ClinicalTrials.gov registry record · Phase 4

Intraoperative Glucose Control in Liver Transplant

A Phase 4 study, sponsored by University of Michigan.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT00780026: Completed Phase 4 study, sponsored by University of Michigan.

NCT00780026 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00780026, a Phase 4 study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The goal of the proposed study is to evaluate the effectiveness of intraoperative, strict glycemic control to improve survival and infection rates following liver transplantation in a randomized, prospective trial.Primary objective: To determine if strict intraoperative blood glucose control, when compared to standard intraoperative glycemic control, improves 1-year recipient survival and decreases surgical complications, including infections, following liver transplantation.

Primary Outcome

Number of participants who sustained an infection after surgery

Interventions

  • DRUG insulin

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2008-07
Est. Completion 2009-09
Phase Phase 4
University of Michigan

1,327 total trials

What the finished NCT00780026 record still lists

NCT00780026 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which insulin is the first listed.

NCT00780026 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00780026 about?

NCT00780026 is a clinical study titled "Intraoperative Glucose Control in Liver Transplant". The goal of the proposed study is to evaluate the effectiveness of intraoperative, strict glycemic control to improve survival and infection rates following liver transplantation in a randomized, prospective trial.Primary objective: To determine if strict intraoperative blood glucose control, when c...

What is the current status of trial NCT00780026?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2008-07. Estimated completion is 2009-09.

What interventions are being tested in trial NCT00780026?

The interventions under investigation include: insulin (DRUG).

Who is sponsoring clinical trial NCT00780026?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00780026's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00780026, the US trial registry maintained by the National Library of Medicine. NCT00780026 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.